Skip to main navigation Skip to search Skip to main content

Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease

  • Daniel M. Blumenthal
  • , Thomas M. Maddox
  • , Krishna Aragam
  • , Chana A. Sacks
  • , Salim S. Virani
  • , Jason H. Wasfy

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Predictors of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitor Prescriptions for Secondary Prevention of Clinical Atherosclerotic Cardiovascular Disease'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology